NRSN

NeuroSense Therapeutics Ltd. - Ordinary Shares (NRSN)

About NeuroSense Therapeutics Ltd. - Ordinary Shares (NRSN)

Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company, which engages n the discovery and development of targeted therapeutics for neurodegenerative diseases. The firm offers PrimeC, a therapy for amyotrophic lateral sclerosis (ALS). It also conducts testing of product candidates for the treatment of Parkinson's and Alzheimer's diseases. The company was founded by Alon Ben-Noon on February 13, 2017 and is headquartered in Herzliya, Israel.

Details

Daily high
$2.01
Daily low
$1.60
Price at open
$1.85
52 Week High
$25.40
52 Week Low
$1.10
Market cap
3.5M
Dividend yield
-
Volume
833
Avg. volume
47,117
P/E ratio
-.16

NeuroSense Therapeutics Ltd. - Ordinary Shares News

Details

Daily high
$2.01
Daily low
$1.60
Price at open
$1.85
52 Week High
$25.40
52 Week Low
$1.10
Market cap
3.5M
Dividend yield
-
Volume
833
Avg. volume
47,117
P/E ratio
-.16